首页 | 本学科首页   官方微博 | 高级检索  
     检索      

What is the recall rate of breast MRI when used for screening asymptomatic women at high risk?
作者姓名:Warren RM  Pointon L  Caines R  Hayes C  Thompson D  Leach MO;UK MRI breast screening study
摘    要:

收稿时间:2 April 2002

What is the recall rate of breast MRI when used for screening asymptomatic women at high risk?
Warren RM,Pointon L,Caines R,Hayes C,Thompson D,Leach MO;UK MRI breast screening study.What is the recall rate of breast MRI when used for screening asymptomatic women at high risk?[J].Magnetic Resonance Imaging,2002,20(7):557-565.
Authors:Warren Ruth M L  Pointon Linda  Caines Rebecca  Hayes Carmel  Thompson Deborah  Leach Martin O;UK MRI breast screening study
Institution:Department of Radiology, Addenbrooke's Hospital, Cambridge, UK. rmlw2@cam.ac.uk
Abstract:Breast screening acceptability is dependent on sensitivity and recall rate. We aimed to establish the recall rate for MRI and mammography, separately and together, when screening a cohort of women at high genetic risk. Women aged 35-49 years in the MARIBS study form the cohort. We analysed the recall rate, the number of extra tests and their effectiveness. Wilcoxon Rank test was used to estimate the effect of age and logistic regression with robust variance the effect of mammographic density on recall rates. The first 726 screening studies took place in 415 women. Following 86 of these recall occurred, comprising 140 additional investigations. 28 of the cases were resolved without further MRI, and 18 women had more than 2 additional tests. Neither age nor mammographic density was associated with recall. MRI had a recall of rate of 10.19%, and mammography 4.00%. The two techniques largely recalled different cases and 10 cases only (11.62% of those recalled) were abnormal by both tests. The two together had a recall rate of 11.85%. Recall rates varied widely between centres of the study. Breast MRI in asymptomatic high-risk women age 35-49 years largely recalls different women from mammography. The combined figure of approximately 12% may be acceptable for screening and will be useful for planning similar studies.
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号